Search Results - "MERCURI, EUGENIO"
-
1
Spinal muscular atrophy — insights and challenges in the treatment era
Published in Nature reviews. Neurology (01-12-2020)“…Spinal muscular atrophy (SMA) is an autosomal recessive motor neuron disease caused by deletion or mutation of SMN1 . Four subtypes exist, characterized by…”
Get full text
Journal Article -
2
Muscular dystrophies
Published in The Lancet (British edition) (09-03-2013)“…Summary Muscular dystrophies are a heterogeneous group of inherited disorders that share similar clinical features and dystrophic changes on muscle biopsy. An…”
Get full text
Journal Article -
3
Duchenne muscular dystrophy
Published in Nature reviews. Disease primers (18-02-2021)“…Duchenne muscular dystrophy is a severe, progressive, muscle-wasting disease that leads to difficulties with movement and, eventually, to the need for assisted…”
Get full text
Journal Article -
4
Risdiplam in Type 1 Spinal Muscular Atrophy
Published in The New England journal of medicine (11-03-2021)“…The small molecule risdiplam increased the expression of SMN protein in blood in 21 infants with type 1 spinal muscular atrophy. Post hoc clinical features of…”
Get full text
Journal Article Web Resource -
5
Childhood spinal muscular atrophy: controversies and challenges
Published in Lancet neurology (01-05-2012)“…Summary Spinal muscular atrophy is an autosomal recessive disorder characterised by degeneration of motor neurons in the spinal cord and is caused by mutations…”
Get full text
Journal Article -
6
The ever-expanding spectrum of congenital muscular dystrophies
Published in Annals of neurology (01-07-2012)“…Congenital muscular dystrophies are a highly heterogeneous group of conditions. In the last few years the identification of several new genes encoding for both…”
Get full text
Journal Article -
7
Spinal muscular atrophy
Published in Orphanet journal of rare diseases (02-11-2011)“…Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease characterized by degeneration of alpha motor neurons in the spinal cord,…”
Get full text
Journal Article -
8
209th ENMC International Workshop: Outcome Measures and Clinical Trial Readiness in Spinal Muscular Atrophy 7–9 November 2014, Heemskerk, The Netherlands
Published in Neuromuscular disorders : NMD (01-07-2015)“…Highlights • An updated classification for SMA is presented. • The utility and limitations of animal models in SMA is discussed. • Biomarkers that are…”
Get full text
Journal Article Conference Proceeding -
9
Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis
Published in Orphanet journal of rare diseases (13-10-2021)“…There is an increasing number of papers reporting the real world use of Nusinersen in different cohorts of SMA patients. Our review suggests that Nusinersen…”
Get full text
Journal Article -
10
Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy
Published in Annals of neurology (01-02-2016)“…Objective To continue evaluation of the long‐term efficacy and safety of eteplirsen, a phosphorodiamidate morpholino oligomer designed to skip DMD exon 51 in…”
Get full text
Journal Article -
11
Revised upper limb module for spinal muscular atrophy: Development of a new module
Published in Muscle & nerve (01-06-2017)“…ABSTRACT Introduction There is a growing need for a robust clinical measure to assess upper limb motor function in spinal muscular atrophy (SMA), as the…”
Get full text
Journal Article -
12
Antepartum and intrapartum factors preceding neonatal hypoxic-ischemic encephalopathy
Published in Pediatrics (Evanston) (01-10-2013)“…To determine whether antepartum factors alone, intrapartum factors alone, or both in combination, are associated with term neonatal hypoxic-ischemic…”
Get full text
Journal Article -
13
Safety update: risdiplam clinical trial programme for spinal muscular atrophy (SMA)
Published in Journal of neurology, neurosurgery and psychiatry (28-11-2023)“…Pooled risdiplam (EVRYSDI®) safety data were analysed from 465 symptomatic patients with Types 1–3 SMA in the FIREFISH (NCT02913482), SUNFISH (NCT02908685) and…”
Get full text
Journal Article -
14
JEWELFISH: 24-month safety and pharmacodynamic data in non-treatment- naïve patients with spinal muscular atrophy (SMA)
Published in Journal of neurology, neurosurgery and psychiatry (28-11-2023)“…Risdiplam (EVRYSDI®) is an oral survival of motor neuron 2 (SMN2) pre-mRNA splicing modifier approved by the EMA and MHRA for the treatment of patients aged ≥2…”
Get full text
Journal Article -
15
Muscle MRI in inherited neuromuscular disorders: Past, present, and future
Published in Journal of magnetic resonance imaging (01-02-2007)“…Interest in muscle MRI has been largely stimulated in the last few years by the recognition of an increasing number of genetic defects in the field of…”
Get full text
Journal Article -
16
Risk Factors for Neonatal Arterial Ischemic Stroke: The Importance of the Intrapartum Period
Published in The Journal of pediatrics (01-06-2016)“…Objective To investigate risk factors for neonatal arterial ischemic stroke (NAIS), and compare them with those present in term controls and infants with…”
Get full text
Journal Article -
17
Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype
Published in Nature genetics (01-06-2012)“…Marcella Zollino and colleagues report mutations in the chromatin regulator KANSL1 in persons with 17q21.31 syndrome. This disorder is marked by distinctive…”
Get full text
Journal Article -
18
Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy
Published in Developmental medicine and child neurology (01-11-2013)“…Aim An international Clinical Outcomes Group consisting of clinicians, scientists, patient advocacy groups, and industries identified a need for a scale to…”
Get full text
Journal Article -
19
Application of the Sleep Disturbance Scale for Children (SDSC) in infants and toddlers (6–36 months)
Published in Sleep medicine (01-05-2021)“…The aim of the present study is to assess the psychometric properties of the Sleep Disturbance Scale for Children (SDSC) in an Italian population of infants…”
Get full text
Journal Article -
20
Longitudinal natural history of type I spinal muscular atrophy: a critical review
Published in Orphanet journal of rare diseases (05-04-2020)“…The advent of new therapies in spinal muscular atrophy (SMA) has highlighted the need to have natural history data for comparison. Natural history studies…”
Get full text
Journal Article